Modeling fragile X syndrome in the Fmr1 knockout mouse

Tatiana M. Kazdoba, Prescott T. Leach, Jill L Silverman, Jacqueline Crawley

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Fragile X Syndrome (FXS) is a commonly inherited form of intellectual disability and one of the leading genetic causes for autism spectrum disorder. Clinical symptoms of FXS can include impaired cognition, anxiety, hyperactivity, social phobia, and repetitive behaviors. FXS is caused by a CGG repeat mutation which expands a region on the X chromosome containing the FMR1 gene. In FXS, a full mutation (> 200 repeats) leads to hypermethylation of FMR1, an epigenetic mechanism that effectively silences FMR1 gene expression and reduces levels of the FMR1 gene product, fragile X mental retardation protein (FMRP). FMRP is an RNA-binding protein that is important for the regulation of protein expression. In an effort to further understand how loss of FMR1 and FMRP contribute to FXS symptomology, several FXS animal models have been created. The most well characterized rodent model is the Fmr1 knockout (KO) mouse, which lacks FMRP protein due to a disruption in its Fmr1 gene. Here, we review the behavioral phenotyping of the Fmr1 KO mouse to date, and discuss the clinical relevance of this mouse model to the human FXS condition. While much remains to be learned about FXS, the Fmr1 KO mouse is a valuable tool for understanding the repercussions of functional loss of FMRP and assessing the efficacy of pharmacological compounds in ameliorating the molecular and behavioral phenotypes relevant to FXS.

Original languageEnglish (US)
Pages (from-to)118-133
Number of pages16
JournalIntractable and Rare Diseases Research
Volume3
Issue number4
DOIs
StatePublished - 2014

Fingerprint

Fragile X Syndrome
Knockout Mice
Fragile X Mental Retardation Protein
Genes
Mutation
RNA-Binding Proteins
X Chromosome
Epigenomics
Intellectual Disability
Cognition
Rodentia
Proteins
Anxiety
Animal Models
Pharmacology
Phenotype
Gene Expression

Keywords

  • anxiety
  • attention
  • behavior
  • cognition
  • Fmr1 knockout mouse
  • Fragile X Syndrome
  • phenotyping
  • social behaviors

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Modeling fragile X syndrome in the Fmr1 knockout mouse. / Kazdoba, Tatiana M.; Leach, Prescott T.; Silverman, Jill L; Crawley, Jacqueline.

In: Intractable and Rare Diseases Research, Vol. 3, No. 4, 2014, p. 118-133.

Research output: Contribution to journalArticle

@article{cca1ac10703b4450a9751a433720788d,
title = "Modeling fragile X syndrome in the Fmr1 knockout mouse",
abstract = "Fragile X Syndrome (FXS) is a commonly inherited form of intellectual disability and one of the leading genetic causes for autism spectrum disorder. Clinical symptoms of FXS can include impaired cognition, anxiety, hyperactivity, social phobia, and repetitive behaviors. FXS is caused by a CGG repeat mutation which expands a region on the X chromosome containing the FMR1 gene. In FXS, a full mutation (> 200 repeats) leads to hypermethylation of FMR1, an epigenetic mechanism that effectively silences FMR1 gene expression and reduces levels of the FMR1 gene product, fragile X mental retardation protein (FMRP). FMRP is an RNA-binding protein that is important for the regulation of protein expression. In an effort to further understand how loss of FMR1 and FMRP contribute to FXS symptomology, several FXS animal models have been created. The most well characterized rodent model is the Fmr1 knockout (KO) mouse, which lacks FMRP protein due to a disruption in its Fmr1 gene. Here, we review the behavioral phenotyping of the Fmr1 KO mouse to date, and discuss the clinical relevance of this mouse model to the human FXS condition. While much remains to be learned about FXS, the Fmr1 KO mouse is a valuable tool for understanding the repercussions of functional loss of FMRP and assessing the efficacy of pharmacological compounds in ameliorating the molecular and behavioral phenotypes relevant to FXS.",
keywords = "anxiety, attention, behavior, cognition, Fmr1 knockout mouse, Fragile X Syndrome, phenotyping, social behaviors",
author = "Kazdoba, {Tatiana M.} and Leach, {Prescott T.} and Silverman, {Jill L} and Jacqueline Crawley",
year = "2014",
doi = "10.5582/irdr.2014.01024",
language = "English (US)",
volume = "3",
pages = "118--133",
journal = "Intractable and Rare Diseases Research",
issn = "2186-3644",
publisher = "International Advancement Center for Medicine & Health Research Co., Ltd. (IACMHR Co., Ltd.)",
number = "4",

}

TY - JOUR

T1 - Modeling fragile X syndrome in the Fmr1 knockout mouse

AU - Kazdoba, Tatiana M.

AU - Leach, Prescott T.

AU - Silverman, Jill L

AU - Crawley, Jacqueline

PY - 2014

Y1 - 2014

N2 - Fragile X Syndrome (FXS) is a commonly inherited form of intellectual disability and one of the leading genetic causes for autism spectrum disorder. Clinical symptoms of FXS can include impaired cognition, anxiety, hyperactivity, social phobia, and repetitive behaviors. FXS is caused by a CGG repeat mutation which expands a region on the X chromosome containing the FMR1 gene. In FXS, a full mutation (> 200 repeats) leads to hypermethylation of FMR1, an epigenetic mechanism that effectively silences FMR1 gene expression and reduces levels of the FMR1 gene product, fragile X mental retardation protein (FMRP). FMRP is an RNA-binding protein that is important for the regulation of protein expression. In an effort to further understand how loss of FMR1 and FMRP contribute to FXS symptomology, several FXS animal models have been created. The most well characterized rodent model is the Fmr1 knockout (KO) mouse, which lacks FMRP protein due to a disruption in its Fmr1 gene. Here, we review the behavioral phenotyping of the Fmr1 KO mouse to date, and discuss the clinical relevance of this mouse model to the human FXS condition. While much remains to be learned about FXS, the Fmr1 KO mouse is a valuable tool for understanding the repercussions of functional loss of FMRP and assessing the efficacy of pharmacological compounds in ameliorating the molecular and behavioral phenotypes relevant to FXS.

AB - Fragile X Syndrome (FXS) is a commonly inherited form of intellectual disability and one of the leading genetic causes for autism spectrum disorder. Clinical symptoms of FXS can include impaired cognition, anxiety, hyperactivity, social phobia, and repetitive behaviors. FXS is caused by a CGG repeat mutation which expands a region on the X chromosome containing the FMR1 gene. In FXS, a full mutation (> 200 repeats) leads to hypermethylation of FMR1, an epigenetic mechanism that effectively silences FMR1 gene expression and reduces levels of the FMR1 gene product, fragile X mental retardation protein (FMRP). FMRP is an RNA-binding protein that is important for the regulation of protein expression. In an effort to further understand how loss of FMR1 and FMRP contribute to FXS symptomology, several FXS animal models have been created. The most well characterized rodent model is the Fmr1 knockout (KO) mouse, which lacks FMRP protein due to a disruption in its Fmr1 gene. Here, we review the behavioral phenotyping of the Fmr1 KO mouse to date, and discuss the clinical relevance of this mouse model to the human FXS condition. While much remains to be learned about FXS, the Fmr1 KO mouse is a valuable tool for understanding the repercussions of functional loss of FMRP and assessing the efficacy of pharmacological compounds in ameliorating the molecular and behavioral phenotypes relevant to FXS.

KW - anxiety

KW - attention

KW - behavior

KW - cognition

KW - Fmr1 knockout mouse

KW - Fragile X Syndrome

KW - phenotyping

KW - social behaviors

UR - http://www.scopus.com/inward/record.url?scp=85010089346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010089346&partnerID=8YFLogxK

U2 - 10.5582/irdr.2014.01024

DO - 10.5582/irdr.2014.01024

M3 - Article

VL - 3

SP - 118

EP - 133

JO - Intractable and Rare Diseases Research

JF - Intractable and Rare Diseases Research

SN - 2186-3644

IS - 4

ER -